Chronic inflammatory demyelinating polyneuropathy following treatment with peglated interferon-2a for chronic hepatitis C virus infection

Neurology India

Volumn 59, Issue 1, 2011, Pages 141-142

  Chang, Ying ^a   Han, Xue Mei ^a   Gao, Yao ^a   Liu, Song Yan ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; DEXAMETHASONE; IMMUNOGLOBULIN; PEGINTERFERON ALPHA2A; PREDNISONE;

ADULT; CASE REPORT; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ELECTRODIAGNOSIS; GENERAL CONDITION DETERIORATION; HEPATITIS C; HEPATITIS C VIRUS; HOFFMANN REFLEX; HUMAN; HYPESTHESIA; LETTER; LIMB WEAKNESS; MALE; MOTOR DYSFUNCTION; MUSCLE STRENGTH; NERVE CONDUCTION; NERVE CONDUCTION DISORDER; PARESTHESIA; PROTEIN BLOOD LEVEL; TENDON REFLEX; TREATMENT DURATION;

ANTIVIRAL AGENTS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; MALE; MIDDLE AGED; NEURAL CONDUCTION; PERIPHERAL NERVES; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;

EID: 79952356288     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.76885     Document Type: Letter

References (14)

1. Konoshi T. A case of myasthenia gravis which developed myaesthenic crisis after alpha-interferon therapy for chronic hepatitis C. Rinsho Shinkeigaku 1996;36:980-5.
2. Hftberger R, Garzuly F, Dienes HP, Grubits J, Rohonyi B, Fischer G, et al. Fulminant central nervous system demyelination associated with interferon-a therapy and hepatitis C virus infection. Mult Scler 2007;13:1100-6. (Pubitemid 351541413)
3. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991;41:617-8.
4. Russo MW, Fried MW. Side effects of therapy for chronic hepatitis C. Gastroenterology 2003;124:1711-9. (Pubitemid 36617688)
5. Tosti A, Misciali C, Bardazzi F, Fanti PA, Varotti C. Telogen effluvium due to recombinant interferon alpha-2b. Dermatology 1992;184:124-5.
6. Formann E, Stauber R, Denk DM, Jessner W, Zollner G, Munda-Steindl P, et al. Sudden hearing loss in patients with chronic hepatitis C treated with peglated interferon/ribavirin. Am J Gastroenterol 2004;99:873-7. (Pubitemid 39090216)
7. Kawano T, Shigehira M, Uto H, Nakama T, Kato J, Hayashi K, et al. Retinal complications during interferon therapy for chronic hepatitis C. Am J Gastroenterol 1996;91:309-13. (Pubitemid 26067340)
8. Meriggioli MN, Rowin J. Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha. Muscle Nerve 2000;23:433-5. (Pubitemid 30126991)
9. Khiani V, Kelly T, Shibli A, Jensen D, Mohanty SR. Acute inflammatory demyelinating polyneuropathy associated with pegylated interferona-2a therpaty for chronic hepatitis C virus infection. World J Gastroenterology 2008;14:318-21. (Pubitemid 351314318)
10. Boz C, Ozmenoglu M, Aktoz G, Velioglu S, Alioglu Z. Guillain-Barre syndrome during treatment with interferon a for hepatitis B. J Clin Neurosci 2004;11:523-5. (Pubitemid 38869486)
11. Hirotani M, Nakano H, Ura S, Yoshida K, Niino M, Yabe I, et al. Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-a. Intern Med 2009;48:373-5.
12. Salomon B, Rhee L, Bour-Jordan H, Hsin H, Montag A, Soliven B, et al. Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. J Exp Med 2001;194:677-84. (Pubitemid 32844777)
13. Press R, Nennesmo I, Kouwenhoven M, Huang YM, Link H, Pashenkov M. Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barr syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol 2005;159:165-76. (Pubitemid 40126189)
14. Radvanyi LG, Banerjee A, Weir M, Messner H. Low levels of interferon-alpha induce CD86 (B7.2) expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells. Scand J Immunol 1999;50:499-509. (Pubitemid 29503456)